Saratov JOURNAL of Medical and Scientific Research

Microinvasive non-surgical treatment of vitreomacular traction

Year: 2018, volume 14 Issue: №4 Pages: 846-849
Heading: Ophtalmology Article type: Original article
Authors: Lyskin P.V., Zakharov V.D., Shpak А.А., Zgoba M.l.
Organization: The S. Fyodorov Eye Microsurgery Federal State Institution
Summary:

Purpose: evaluation of the effectiveness of treatment for vitreomacular traction below 500 urn in length uncomplicated by epiretinal fibrosis and macular holes. Material and Methods. Enzymatic vitreolysis was used to treat 23 patients (23 eyes) with uncomplicated vitreomacular traction up to 500 urn in length. Results. Elimination of vitreomacular traction was achieved in 17 cases (74%). The goal of intervention was not achieved in 5 cases (21 %), in 1 case (5%) a macular hole was formed. Conclusion. The results have shown that enzymatic vitreolysis can be a method of choice for treatment of vitreomacular traction up to 500 urn uncomplicated by epiretinal fibrosis and macular holes.

Bibliography:
1. Stalmans P, Benz MS, GandorferA, and MIVI-TRUSTStudy Group. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med 2012; 367 (7): 606-15
2. Maier M, Abraham S, Frank C, et al. Ocriplasmin as a treatment option for symptomatic vitreomacular traction with and without macular hole.:First clinical experiences. Ophthalmology 2015; 112 (12): 990-4
3. Steel DH, Wong D. Ocriplasmin — variable efficacy? Graefe's archive for clinical and experimental ophthalmology 2016; 254 (7): 1245-6
4. Brian О Joondeph. T
e Jetrea Landscape at 6 Years: A cost-effective treatment option with good outcomes in select patient populations. Retinal Physician 2018; 15: 50-2, 54-8
5. Smiddy William E. Patient Selection for Ocriplasmin Treatment of Patients with VMT: The honeymoon is over, but the marriage is stable. Retinal Physician 2015; 12: 19, 20, 22.

AttachmentSize
2018_4-2_846-849.pdf1.84 MB

No votes yet